Skip to main content
Premium Trial:

Request an Annual Quote

Kreatech to Use GE Healthcare Dyes in Microarray Kits

This article has been corrected from a previous version that ran yesterday. GE Healthcare is providing the Cy3 and Cy5 dyes under the agreement, not the Universal Linkage System, which was developed by Kreatech. 

NEW YORK, Feb. 22 (GenomeWeb News) - Kreatech Biotechnology said yesterday that it has signed an agreement allowing it to use GE Healthcare's Cy3 and Cy5 dyes in combination with its Universal Linkage System in DNA microarray-labeling kits.

Under the terms of the agreement, Kreatech gains global rights for the use of Cy3 and Cy5 dyes with the Universal Linkage System in fluorescent applications within the life sciences market, Kreatech said. Kreatech will use the technology to develop and manufacture microarray-labeling kits for amplified RNA labeling and genomic DNA labeling, it said.

Kreatech said the technology enables direct DNA labeling, negating the need for modified nucleotides.

Financial terms of the deal were not disclosed.

The Scan

Just Breathing

A new analysis suggests that most Mycobacterium tuberculosis is spread by aerosols from breathing, rather than by coughing, the New York Times reports.

Just Like This One

NPR reports that the World Health Organization has hired a South African biotech company to recreate mRNA vaccine for SARS-CoV-2 that is similar to the one developed by Moderna.

Slow Start

The Wall Street Journal reports that Biogen's Alzheimer's disease treatment had revenues for July through September that totaled $300,000.

Genome Research Papers on Cancer Chromatin, Splicing in the Thymus, Circular RNAs in Cancer

In Genome Research this week: analysis of bivalent chromatin sites, RBFOX splicing factors' role in thymic epithelial cells, and more.